PMID: 2894080Dec 1, 1987

Effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5'-monophosphate in non-atopic asthma

Thorax
G D PhillipsS T Holgate

Abstract

Inhaled adenosine 5'-monophosphate (AMP) causes bronchoconstriction in atopic asthma, probably after in vivo conversion to adenosine. It has been suggested that adenosine potentiates preformed mediator release from mast cells on the mucosal surface of the airways by interacting with specific purinoceptors, without affecting the release of newly generated mediators. The airway response of nine non-atopic subjects with "intrinsic" asthma to inhaled AMP and the influence of the oral, selective H1 histamine receptor antagonist terfenadine on this response was investigated. The geometric mean provocation concentrations of histamine and AMP required to produce a 20% fall in FEV1 (PC20) were 1.82 and 13 mmol/l. In subsequent placebo controlled time course studies the FEV1 response to a single inhalation of the PC20 histamine was ablated after pretreatment with oral terfenadine 180 mg. This dose of terfenadine caused an 80% inhibition of the bronchoconstrictor response to the PC20 AMP when measured as the area under the time course-response curve and compared with the response to PC20 AMP preceded by placebo. Terfenadine 600 mg failed to increase protection against AMP further, but both doses of terfenadine delayed the time at which th...Continue Reading

References

Jul 1, 2001·Indian Journal of Clinical Biochemistry : IJCB·S B Rao
Mar 26, 2011·Journal of Clinical Immunology·Gregorio GomezLawrence B Schwartz
Jun 5, 1998·Trends in Pharmacological Sciences·I FeoktistovI Biaggioni
Sep 1, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S R RutgersD S Postma
Sep 6, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J R Fozard, J P Hannon
Jun 6, 2002·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M van den BergeD S Postma
Oct 22, 1992·The New England Journal of Medicine·B J O'ConnorP J Barnes
Mar 21, 2013·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Anne J LexmondAnne H de Boer
Aug 1, 1990·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S J Rimmer, M K Church
Mar 28, 1998·American Journal of Respiratory and Critical Care Medicine·S R RutgersD S Postma
Jun 3, 1999·American Journal of Respiratory and Critical Care Medicine·J A NightingaleP J Barnes
Jun 13, 2001·American Journal of Respiratory and Critical Care Medicine·M van den BergeD S Postma
Aug 1, 1989·The American Review of Respiratory Disease·G D PhillipsS T Holgate
Jul 1, 1993·The American Review of Respiratory Disease·P G GibsonF E Hargreave
Jul 1, 1993·The American Review of Respiratory Disease·A G DriverS J Mustafa
May 16, 2006·Treatments in Respiratory Medicine·Andrew M Wilson
Mar 4, 2008·British Journal of Pharmacology·R A BrownC P Page
Jan 1, 1989·Pulmonary Pharmacology·R PolosaM K Church
Nov 30, 2004·Journal of Clinical Epidemiology·Catherine S BirkenColin Macarthur
Oct 2, 2003·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·G P CurrieB J Lipworth
Jan 15, 2004·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·G de MeerD S Postma
Mar 1, 1989·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·C K LaiS T Holgate
Jul 1, 1989·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·G D PhillipsS T Holgate
Apr 20, 2005·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·N Smith, F J Johnson
Feb 1, 1988·British Journal of Clinical Pharmacology·K A MiszkielS T Holgate

Citations

Jun 15, 1979·Molecular and Cellular Biochemistry·J N Fain, C C Malbon
Oct 1, 1975·The Journal of Allergy and Clinical Immunology·H ChaiR G Townley
Feb 1, 1987·The Journal of Allergy and Clinical Immunology·K R Patel
Feb 1, 1985·The Journal of Allergy and Clinical Immunology·M J Cushley, S T Holgate
May 1, 1985·British Journal of Clinical Pharmacology·J S Mann, S T Holgate
Feb 1, 1983·British Journal of Clinical Pharmacology·M J CushleyS T Holgate
Oct 1, 1982·The Journal of Clinical Investigation·D W MacGlashanL M Lichtenstein
Feb 15, 1981·Biochemical Pharmacology·S Webster, R A Olsson
Nov 1, 1947·The American Journal of Medicine·F M RACKEMANN

Related Concepts

Terfenadine 600 MG
Histamine Measurement
Inhalation of Drugs
Dermatitis, Atopic
Adenosine
Mast Cell
Bronchoconstrictor Agents
Purinoceptor
Bronchial Provocation Tests
Mucous Membrane of Bronchus

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.